Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
OptimizeRx (OPRX) Stock Price & Analysis
451 Followers
OPRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.92 - $16.65
Previous Close$10
Volume30.03K
Average Volume (3M)139.82K
Market Cap
$183.98M
Enterprise Value$206.95M
Total Cash (Recent Filing)$13.85M
Total Debt (Recent Filing)$36.82M
Price to Earnings (P/E)―
Beta2.43
Next Earnings
Aug 07, 2024EPS Estimate
-$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.02
Shares Outstanding18,269,823
10 Day Avg. Volume80,528
30 Day Avg. Volume139,816
Standard Deviation0.19
R-Squared0.12
Alpha-0.00169
Financial Highlights & Ratios
Price to Book (P/B)-161.00
Price to Sales (P/S)2.70
Price to Cash Flow (P/CF)-7.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.89
Enterprise Value/Gross Profit4.82
Enterprise Value/Ebitda-10.94
Forecast
1Y Price Target
$16.33Price Target Upside63.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
OptimizeRx News
PremiumCompany Announcements
OptimizeRx Stockholders Approve Expansion and Elect Directors
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRevenue of $19.7M represented a significant increase, highlighting strong financial performance.
Market PositioningThe acquisition of Medicx should meaningfully increase OptimizeRx's growth opportunity by adding a direct-to-consumer marketing platform.
Stock ValuationShares of OptimizeRx recently traded at a discount to its two-year average, presenting a compelling entry point.
Bears Say
Accounting PracticesOptimizeRx's shift in treatment of certain Medicx revenue to net, from gross, is not ideal.
Financial HealthOperational cash burn was reported, indicating a potential area of concern.
Revenue GuidanceOptimizeRx lowered its revenue guidance for the following year to 'at least $100M,' from a previous 'at least $110M.'
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
OPRX FAQ
What was OptimizeRx Corporation’s price range in the past 12 months?
OptimizeRx Corporation lowest stock price was $6.92 and its highest was $16.64 in the past 12 months.
What is OptimizeRx Corporation’s market cap?
Currently, no data Available
When is OptimizeRx Corporation’s upcoming earnings report date?
OptimizeRx Corporation’s upcoming earnings report date is Aug 07, 2024 which is in 33 days.
How were OptimizeRx Corporation’s earnings last quarter?
Currently, no data Available
Is OptimizeRx Corporation overvalued?
According to Wall Street analysts OptimizeRx Corporation’s price is currently Undervalued.
Does OptimizeRx Corporation pay dividends?
OptimizeRx Corporation does not currently pay dividends.
What is OptimizeRx Corporation’s EPS estimate?
OptimizeRx Corporation’s EPS estimate is -$0.07.
How many shares outstanding does OptimizeRx Corporation have?
OptimizeRx Corporation has 18,269,823 shares outstanding.
What happened to OptimizeRx Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of OptimizeRx Corporation?
Among the largest hedge funds holding OptimizeRx Corporation’s share is S Squared Technology, LLC. It holds OptimizeRx Corporation’s shares valued at N/A.
---
OptimizeRx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.33 (63.30% Upside)
$16.33 (63.30% Upside)
Blogger Sentiment
Bullish
OPRX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 17.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 9.9%
Last 30 Days ▼ 9.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.57%
12-Months-Change
Fundamentals
Return on Equity
-14.66%
Trailing 12-Months
Asset Growth
33.92%
Trailing 12-Months
Company Description
OptimizeRx Corporation
OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.
---
OPRX Earnings Call
Q1 2024
0:00 / 0:00
---
OPRX Stock 12 Month Forecast
Average Price Target
$16.33
▲(63.30% Upside)
Technical Analysis
Best Analysts Covering OPRX
1 Year
1 Year Success Rate
7/13 ratings generated profit
1 Year Average Return
+37.74%
reiterated a buy rating 3 months ago
Copying Richard Baldry's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of +37.74% per trade.
---